Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kodiak Sciences Inc.

4.80
+0.31006.90%
Post-market: 4.800.00000.00%16:05 EDT
Volume:614.32K
Turnover:2.95M
Market Cap:252.61M
PE:-1.43
High:5.04
Open:4.52
Low:4.52
Close:4.49
Loading ...

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases

PR Newswire
·
Yesterday

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD)

Zacks
·
01 Apr

Kodiak Sciences Price Target Maintained With a $3.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Mar

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kodiak Sciences (KOD), Tempest Therapeutics (TPST) and EDAP TMS (EDAP)

TIPRANKS
·
29 Mar

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus

Zacks
·
28 Mar

Kodiak Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
28 Mar

Kodiak Sciences Q4 EPS ($0.84) Up From ($1.13) YoY.

Benzinga
·
28 Mar

BRIEF-Kodiak Sciences Q4 Net Income USD -44.105 Million Vs. IBES Estimate USD -45 Million

Reuters
·
28 Mar

Kodiak Sciences Q4 Operating Income USD -46.179 Million VS. Ibes Estimate USD -49.3 Million

THOMSON REUTERS
·
28 Mar

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

PR Newswire
·
28 Mar

Is Kodiak Sciences Inc. (KOD) The Hot Biotech Stock Under $5?

Insider Monkey
·
27 Mar

Kodiak Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview

Reuters
·
24 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate

Zacks
·
11 Mar

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial

TIPRANKS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients With Diabetic Retinopathy

THOMSON REUTERS
·
11 Mar

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

PR Newswire
·
11 Mar

Kodiak Sciences granted orphan designation for tabirafusp alfa

TIPRANKS
·
05 Mar

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate

Simply Wall St.
·
25 Feb

Canaccord Genuity Sticks to Their Buy Rating for Kodal Minerals (KOD)

TIPRANKS
·
12 Feb